Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USA

Objectives Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM in England is among the highest in Europe. This paper aims to assess the association of variation in use of definitive therapy on risk-adjusted PCM in England as compared with the USA. Design Observational study. Setting Cancer registry data from England and the USA. Participants Men diagnosed with non-metastatic prostate cancer (PCa) in England...